Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Pre-Open 09/06: (DOCU) (GCO) (TNAV) Higher (DOMO) (MDLZ) (PD) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Ekso Bionics (EKSO) at Overweight on Unique Value Proposition
-
Cantor Fitzgerald Starts Durect Corp (DRRX) at Overweight
-
uniQure (QURE) Prices 4.89M Share Common Offering at $46/Sh
-
uniQure Announces Pricing of its Public Offering
-
After-Hours Movers 09/05: (NTGN) (IMUX) (DOCU) Higher; (DOMO) (MDLA) (PD) Lower (more...)
-
Cantor Fitzgerald Starts Repay (RPAy) at Overweight
-
Cantor Fitzgerald Starts Kadmon Holdings (KDMN) at Overweight
-
TransEnterix (TRXC) Prices 28M Share Common Offering for Gross Proceeds of Approx. $20.3M
-
TransEnterix Announces Pricing of Public Offering of Common Stock
-
Amgen (AMGN) PT Raised to $230 at Cantor Fitzgerald Ahead of World Lung
-
Scholar Rock to Present at Upcoming Healthcare Conferences
-
Scholar Rock to Present at Upcoming Healthcare Conferences
-
TransEnterix (TRXC) Plans Public Offering of Common Stock
-
TransEnterix Announces Proposed Public Offering of Common Stock
-
uniQure (QURE) Announces Proposed $200M Share Common Offering
-
uniQure Announces Proposed Public Offering
-
Selecta Biosciences (SELB) Names Brad Dahms as CFO
-
Mereo BioPharma Announces Setrusumab 6-Month Phase 2b Data in Osteogenesis Imperfecta Selected for Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research (ASBMR) 2019 An
-
Spring Bank Announces $20 Million Strategic Debt Financing Agreement with Pontifax Medison Finance
-
Mereo BioPharma Announces Setrusumab 6-Month Phase 2b Data in Osteogenesis Imperfecta Selected for Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research (ASBMR) 2019 An
-
Selecta Biosciences Appoints Brad Dahms as Chief Financial Officer
-
Coupa Software (COUP) PT Raised to $166 at Cantor Fitzgerald
-
Amarin Corporation (AMRN): AdCom and sNDA Concerns are Overdone - Cantor Fitzgerald
-
Cantor Fitzgerald Starts Correvio Pharma Corp. (CORV) at Overweight
-
Yields rise on trade optimism, volumes muted
-
AAC Holdings (AAC) Misses Q2 EPS by 40c, Revenues Miss; Offers FY19 EPS/Revenue Guidance Below Consensus
-
AAC Holdings, Inc. Reports Second Quarter 2019 Results
-
Cantor Fitzgerald Reiterates Overweight Rating on Ascendis Pharma (ASND)
-
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
-
Veru to Participate at Three Upcoming Healthcare Investor Conferences in New York
-
Omnicell (OMCL) Analyst Briefing Shows Off Solution Sales and Cross Selling Opportunities - Cantor
-
Royal Nickel (RNC Mineral) (RNX:CN) (RNKLF) PT Lowered to Cdn$1 at Cantor Fitzgerald
-
Tactile Medical to Present at Two Upcoming Investor Conferences in September and October
-
Acadia Pharmaceuticals (ACAD) PT Raised to $40 at Cantor Fitzgerald on KOL Support For Pimavanserin
-
Legacy Acquisition Corp. and Blue Impact Announce Business Combination
-
Fintech firm Pagaya issuing $115 million asset-backed security
-
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in September and October
-
Pagaya Expands PAID Shelf with Prosper: Closing $115 Million Consumer Credit ABS
-
First Mining Establishes At-The-Market Facility
-
Cantor Fitzgerald Reiterates Overweight Rating on PolarityTE (PTE)
-
AnaptysBio (ANAB) CFO Resignation Is Not A Read Into Trials - Cantor
-
Lineage Cell Therapeutics to Ring Opening Bell at the New York Stock Exchange on August 21, 2019
-
Sarepta Therapeutics (SRPT) PT Lowered to $175 at Cantor Fitzgerald
-
Oil steadies as hopes of easing trade tensions lend support
-
Foamix (FOMX) Enters Sale Agreement with Cantor Fitzgerald Covering up to $30M in Stock
-
Cantor Fitzgerald Starts Immunomedics (IMMU) at Overweight
-
U.S. SEC fines Cantor, BMO Capital Markets over improper handling of ADRs
-
U.S. 30-year yields drop to record low; 10-year yields sink
-
Pre-Open Movers 08/15: (PVTL) (JCP) (WMT) Higher; (BGG) (TPR) (CSCO) (more...)

